nad has been researched along with Disease Exacerbation in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 10 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, H; Kim, MB; Lee, JY; Park, YK | 1 |
| Chen, X; Gao, M; Hu, C; Li, W; Zhou, Y | 1 |
| Miller, R; Richards, GA; Wentzel, AR | 1 |
| Cai, Y; Li, X | 1 |
| Xia, J; Xu, B; Zhao, N | 1 |
| Fei, Z; Jing, Z; Lijuan, Y; Shuwen, H; Xi, Y; Yuefen, P | 1 |
| Harigae, H; Hashizume, Y; Ito, S; Kumakura, S; Miyazaki, M; Sato, E; Sekimoto, A; Takahashi, N; Yamakage, S | 1 |
| Kretzschmar, T; Schulze, PC; Wu, JMF | 1 |
| Allen, SP; Allsop, J; Gerou, M; Hall, B; Kolb, SJ; Meyer, K; Shaw, PJ; Woof, R | 1 |
| Andersen, CB; Egstrand, S; Lewin, E; Mace, ML; Morevati, M; Nordholm, A; Olgaard, K; Salmani, R | 1 |
| Brooks, HL; Coombes, JS; Gobe, GC; Johnson, DW; Morais, C; Roy, SF; Sanchez, WY; Small, DM | 1 |
| Cox, BL; Eliceiri, KW; Erickson-Bhatt, S; Fain, SB; Ludwig, KD; Macdonald, EB; Ponik, SM; Squirrell, JM; Swader, R; Szulczewski, JM | 1 |
| Cao, Y; Gao, M; He, Y; Liu, S; Tang, H; Tao, Y | 1 |
| Felding-Habermann, B; Gay, LJ; LeBoeuf, SE; Matsuno-Yagi, A; Ritland, M; Santidrian, AF; Seo, BB; Yagi, T | 1 |
| Braidy, N; Brew, BJ; Grant, R; Guillemin, GJ; Lim, CK | 1 |
| Devi, S; Panigrahi, PK; Pradhan, A | 1 |
| Bonder, CS; Pastore, MN; Roberts, MS; Studier, H | 1 |
| Conklin, MW; Eliceiri, KW; Keely, PJ; Provenzano, PP; Rueden, CT | 1 |
| Bi, TQ; Che, XM | 1 |
| Barton, JK; Brewer, MA; Hoyer, PB; Marion, SL; Rice, PF; Utzinger, U; Watson, JM | 1 |
| Anderson, RE; Sharbrough, FW; Sundt, TM | 1 |
| Cosi, C; Fluit, P; Gallo-Hendrikx, E; Marien, MR; Martel, JC; Mount, HT; Wu, Y | 1 |
| Bergendahl, K; Daley, TJ; Garriga-Canut, M; Morrison, JF; Ockuly, J; Pfender, RM; Qazi, R; Roopra, A; Schoenike, B; Stafstrom, C; Sutula, T | 1 |
| Fang, JS; Gatenby, RA; Gillies, RD | 1 |
5 review(s) available for nad and Disease Exacerbation
| Article | Year |
|---|---|
NMNAT2: An important metabolic enzyme affecting the disease progression.
Topics: Axons; Disease Progression; Humans; NAD; Neurodegenerative Diseases; Nicotinamide-Nucleotide Adenylyltransferase; Wallerian Degeneration | 2023 |
Mitochondrial Homeostasis Mediates Lipotoxicity in the Failing Myocardium.
Topics: Adipose Tissue; Calcium Signaling; Cardiomyopathies; Ceramides; Citric Acid Cycle; Disease Progression; Fatty Acids; Heart Failure; Homeostasis; Humans; Ketone Bodies; Mitochondria, Heart; Mitochondrial Diseases; Mitochondrial Dynamics; Mitophagy; NAD; Pericardium; Peroxisome Proliferator-Activated Receptors; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2021 |
Metabolic Intermediates in Tumorigenesis and Progression.
Topics: Acetyl Coenzyme A; Antineoplastic Agents; Carcinogenesis; Cell Proliferation; Disease Progression; Flavin-Adenine Dinucleotide; Humans; NAD; Neoplasm Invasiveness; Neoplasms; S-Adenosylmethionine; Tetrahydrofolates | 2019 |
Nampt/PBEF/visfatin and cancer.
Topics: Acrylamides; Cytokines; Disease Progression; Humans; NAD; Neoplasms; Nicotinamide Phosphoribosyltransferase; Piperidines; Signal Transduction | 2010 |
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression.
Topics: Adaptation, Biological; Cell Hypoxia; Cell Proliferation; Disease Progression; Humans; Hydrogen-Ion Concentration; NAD; Neoplasms; Transcription Factors | 2008 |
19 other study(ies) available for nad and Disease Exacerbation
| Article | Year |
|---|---|
A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD
Topics: Alcoholism; Animals; Disease Models, Animal; Disease Progression; Ethanol; Fatty Liver; Hepatitis, Alcoholic; Humans; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; NAD; Oxidative Stress; Sirtuin 1 | 2022 |
COVID-19: NAD
Topics: ADAM17 Protein; ADP-ribosyl Cyclase 1; Age Factors; Aged; Aging; COVID-19; Diabetes Mellitus, Type 2; Disease Progression; Disease Susceptibility; Humans; Inflammation; Membrane Glycoproteins; NAD; Obesity; Oxidative Stress; Protein Binding; Sirtuin 1; Virus Replication; Zinc | 2020 |
Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
Topics: Biomarkers, Tumor; Clinical Decision-Making; Databases, Genetic; Decision Support Techniques; Disease Progression; Female; Gene Expression Profiling; Gene Regulatory Networks; GTP Phosphohydrolases; Humans; Intraepithelial Lymphocytes; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Membrane Proteins; Middle Aged; NAD; Neurofibromin 1; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins B-raf; Reproducibility of Results; Risk Assessment; Risk Factors; RNA-Seq; Skin Neoplasms; T-Lymphocytes, Regulatory; Transcriptome; Tumor Microenvironment | 2020 |
Physical exercise may exert its therapeutic influence on Alzheimer's disease through the reversal of mitochondrial dysfunction via SIRT1-FOXO1/3-PINK1-Parkin-mediated mitophagy.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Brain-Derived Neurotrophic Factor; Disease Progression; Exercise; Forkhead Box Protein O1; Humans; Mitochondria; Mitochondrial Diseases; Mitophagy; NAD; Niacinamide; Nicotinamide Mononucleotide; Protein Kinases; Pyridinium Compounds; Reactive Oxygen Species; Sirtuin 1; Ubiquitin-Protein Ligases | 2021 |
Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.
Topics: Activating Transcription Factor 3; Alanine; Carcinoma, Hepatocellular; Disease Progression; Ferroptosis; Gene Expression Regulation, Neoplastic; Genetic Association Studies; Glutamic Acid; Heat-Shock Proteins; Humans; Liver Neoplasms; MAP Kinase Signaling System; Molecular Chaperones; NAD; Survival Rate | 2021 |
Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease.
Topics: Adenine; Animals; Citric Acid Cycle; Disease Models, Animal; Disease Progression; Energy Metabolism; Glycolysis; Kidney; Male; Metabolic Networks and Pathways; Metabolome; Mice; Mice, Inbred C57BL; NAD; Niacinamide; Renal Insufficiency; Renal Insufficiency, Chronic | 2021 |
Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts.
Topics: Adult; Aged; Aging; Amyotrophic Lateral Sclerosis; Citric Acid Cycle; Disease Progression; Energy Metabolism; Female; Fibroblasts; Glycogen; Glycolysis; Humans; Inosine; Ketoglutaric Acids; Male; Middle Aged; NAD | 2021 |
Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
Topics: Acute Kidney Injury; Animals; Autophagy; Disease Progression; Fibrosis; Glucuronidase; Kidney; Klotho Proteins; Male; Mitochondria; NAD; Niacinamide; Protective Agents; Pyridinium Compounds; Random Allocation; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Reperfusion Injury; Signal Transduction; Sirtuin 1; Treatment Outcome | 2021 |
N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Proliferation; Disease Models, Animal; Disease Progression; Energy Metabolism; Kidney; Male; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Mitochondria; NAD; Oxidative Stress; Phosphorylation; PPAR gamma; Renal Insufficiency, Chronic; Signal Transduction; Time Factors; Transforming Growth Factor beta1 | 2018 |
A novel bioreactor for combined magnetic resonance spectroscopy and optical imaging of metabolism in 3D cell cultures.
Topics: Animals; Bioreactors; Cell Line, Tumor; Cell Survival; Collagen; Contrast Media; Diffusion; Disease Progression; Equipment Design; Female; Gels; Glucose; Lactic Acid; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; NAD; Optical Imaging; Printing, Three-Dimensional; Pyruvic Acid; Temperature | 2019 |
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression.
Topics: Acrylamides; Animals; Autophagy; Autophagy-Related Protein 5; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cytokines; Disease Progression; Electron Transport Complex I; Female; Gene Knockdown Techniques; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred BALB C; Mice, SCID; Microtubule-Associated Proteins; Mitochondria; Multiprotein Complexes; NAD; Neoplasm Transplantation; Niacin; Niacinamide; Nicotinamide Phosphoribosyltransferase; Piperidines; Protein Transport; Proteins; Recombinant Proteins; Saccharomyces cerevisiae Proteins; TOR Serine-Threonine Kinases | 2013 |
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
Topics: Disease Progression; Female; Humans; Male; Multiple Sclerosis; NAD; Recurrence | 2013 |
Detecting cervical cancer progression through extracted intrinsic fluorescence and principal component analysis.
Topics: Cervix Uteri; Collagen; Disease Progression; Female; Flavin-Adenine Dinucleotide; Humans; NAD; Optical Imaging; Porphyrins; Principal Component Analysis; Sensitivity and Specificity; Spectrometry, Fluorescence; Uterine Cervical Neoplasms | 2014 |
Non-invasive metabolic imaging of melanoma progression.
Topics: Animals; Cell Line, Tumor; Disease Progression; Epidermis; Female; Keratinocytes; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; NAD; Neoplasm Staging; Skin Neoplasms | 2017 |
Nonlinear optical microscopy and computational analysis of intrinsic signatures in breast cancer.
Topics: Algorithms; Breast Neoplasms; Collagen; Disease Progression; Equipment Design; Humans; Image Processing, Computer-Assisted; Microscopy; Microscopy, Fluorescence; NAD; Neoplasm Metastasis; Optics and Photonics; Programming Languages; Software | 2009 |
Two-photon excited fluorescence imaging of endogenous contrast in a mouse model of ovarian cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Aging; Animals; Biomarkers, Tumor; Collagen; Cyclohexenes; Disease Progression; Elastin; Female; Image Interpretation, Computer-Assisted; Linear Models; Lipofuscin; Mice; Microscopy, Fluorescence, Multiphoton; NAD; Ovarian Neoplasms; Ovary; Vinyl Compounds | 2013 |
Effect of hypocapnia, hypercapnia, and blood pressure on NADH fluorescence, electrical activity, and blood flow in normal and partially ischemic monkey cortex.
Topics: Animals; Arteries; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cerebral Cortex; Cerebrovascular Circulation; Disease Progression; Electroencephalography; Hypercapnia; Hypocapnia; Hypoxia; Ischemic Attack, Transient; NAD; Saimiri; Sensitivity and Specificity; Spectrometry, Fluorescence | 1976 |
Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Catecholamines; Cell Cycle Proteins; Cerebellum; Corpus Striatum; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Dopamine; Mesencephalon; Mice; Mice, Knockout; NAD; NADP; Protein Serine-Threonine Kinases; Psychomotor Performance; Sex Factors; Tumor Suppressor Proteins | 2004 |
2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure.
Topics: Alcohol Oxidoreductases; Animals; Antimetabolites; Chromatin; Deoxyglucose; Diet; Disease Progression; DNA-Binding Proteins; Down-Regulation; Energy Metabolism; Epilepsy; Gene Expression; Glycolysis; Hippocampus; Kindling, Neurologic; NAD; Neuronal Plasticity; Rats; Receptor, trkB; Repressor Proteins; Transcription Factors | 2006 |